雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Drugs under Development (Neurosurgery) Tetsuya Ueba 1 1Department of Neurosurgery, Kochi Medical School Keyword: テセルパツレブ , がんウイルス療法 , ヒト(自己)骨髄由来間葉系幹細胞 , teserpaturev , viral gene-therapy , mesenchymal stem cell pp.433-436
Published Date 2023/5/1
DOI https://doi.org/10.11477/mf.1416202355
  • Abstract
  • Look Inside
  • Reference

Abstract

In this section, new arsenals for neurological treatment based on an open source are introduced. “Delytact” and “Stemirac” are discussed in this section. These two new arsenals have been accepted as cell and gene therapy products by the Ministry of Health, Labor, and Welfare. “Delytact” is a viral-gene therapy that targets malignant brain tumors, such as malignant gliomas, while “Stemirac” targets against spinal contusion via self-mesenchymal implantation. Both are permitted clinical arsenals in Japan.


Copyright © 2023, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有